- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 407/04 - Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group containing two hetero rings directly linked by a ring-member-to-ring- member bond
Patent holdings for IPC class C07D 407/04
Total number of patents in this class: 718
10-year publication summary
|
48
|
42
|
48
|
50
|
40
|
51
|
36
|
40
|
43
|
20
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Merck Patent GmbH | 5823 |
21 |
| LG Chem, Ltd. | 17638 |
20 |
| F. Hoffmann-La Roche AG | 7921 |
10 |
| Janssen Pharmaceutica N.V. | 3383 |
10 |
| Green Cross Corporation | 202 |
9 |
| Hoffmann-La Roche Inc. | 3422 |
8 |
| Syngenta Participations AG | 1902 |
8 |
| Daewoong Pharmaceutical Co., Ltd. | 324 |
8 |
| SynDevRx, Inc. | 47 |
8 |
| LT Materials Co., Ltd. | 408 |
8 |
| Bristol-myers Squibb Company | 4893 |
7 |
| BASF SE | 20915 |
7 |
| Tokuyama Corporation | 1392 |
7 |
| Novartis AG | 10850 |
6 |
| Centre National de La Recherche Scientifique | 10432 |
6 |
| Cumberland Pharmaceuticals Inc. | 101 |
6 |
| FMC Corporation | 844 |
6 |
| JNC Corporation | 1561 |
6 |
| Vanderbilt University | 1904 |
6 |
| Samsung Display Co., Ltd. | 34798 |
5 |
| Other owners | 546 |